NCT03865992View on ClinicalTrials.gov

Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 4, 2019

Primary Completion Date

October 17, 2025

Study Completion Date

October 17, 2025

Conditions
Breast CancerJoint Pain
Interventions
DIETARY_SUPPLEMENT

Curcumin

Given capsules for oral administration

OTHER

Placebo

Given capsules for oral administration

OTHER

Nanoemulsion

Given nanoemulsion curcumin PO

OTHER

Quality-of-Life Assessment

Ancillary studies

BEHAVIORAL

Questionnaire

Ancillary studies

Trial Locations (4)

43210

Ohio State University Comprehensive Cancer Center, Columbus

91010

City of Hope Medical Center, Duarte

91030

City of Hope South Pasadena, South Pasadena

91730

City of Hope Rancho Cucamonga, Rancho Cucamonga

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT03865992 - Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease | Biotech Hunter | Biotech Hunter